Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TT Electronics Hires Ex-Exova Finance Chief Thorburn Non-Exec Director

Wed, 12th Jun 2019 12:35

(Alliance News) - TT Electronics PLC said Wednesday it hired Anne Thorburn as non-executive director of the electrical engineer from the start of July.

Thorburn currently serves as non-executive at Diploma PLC and BTG PLC. Until 2015, she was chief financial officer at Exova PLC having previously served as finance chief at British Polythene Industries.

TT Chair Neil Carson explained he was "delighted" Thorburn was joining the firm.

"She has many years of experience at board level in listed international businesses, including those operating in life sciences and medical markets, where TT has a growing presence," Carson said, adding that she "has particular expertise in financial management, risk, audit and M&A and I am sure she will make a valuable contribution to the ongoing transformation of TT."

Shares in TT were 2.5% lower at 236.00 pence in London on Wednesday.

More News
15 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 14:59

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 15:07

AGM, EGM Calendar - Week Ahead

Read more
13 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 16:11

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 15:21

AGM, EGM Calendar - Week Ahead

Read more
9 Jul 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more
8 Jul 2015 15:20

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 14:51

Investec affirms 'buy' rating for BTG, confident about varicose vein treatment

Investec reiterated a 'buy' rating and price target of 647p for pharmaceuticals firm BTG after reappraising its key product Varithena. The bank said investors overreacted to concerns over BTG's earning profile, in particular the varicose vein treatment Varithena. "After interviewing physicians and

Read more
11 Jun 2015 10:26

WINNERS & LOSERS: RBS Rises, Royal Mail Sinks On UK Government Moves

Read more
11 Jun 2015 08:35

BROKER RATINGS SUMMARY: Liberum Raises Majestic Wine To Buy From Hold

Read more
11 Jun 2015 06:39

BTG Says First Patient Treated With TheraSphere In Singapore

Read more
27 May 2015 08:34

BROKER RATINGS SUMMARY: Brewin Dolphin Cut To Hold By Peel Hunt, Numis

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.